Fundz

Cerus Corporation Announces Award Of U.S. Department Of Defense Funding For Development Of Pathogen Reduced, Lyophilized Cryoprecipitate

PUBLIC · CERSNov 02, 2022

Round Type

Grant

ConcordManufacturingBiotechnologyHealth Care

Description

Cerus Corporation (Nasdaq: CERS) today announced that it has been awarded a $9.1 million contract by the U.S. Department of Defense (DoD) Industrial Base Analysis and Sustainment (IBAS) program for the development of pathogen reduced, lyophilized cryoprecipitate (“LyoCryo”) to treat bleeding due to trauma.

Quick answer

Cerus raised an undisclosed amount in a Grant round, dated November 2, 2022. Cerus is based in Concord, Massachusetts, United States.

How much did Cerus raise?
Cerus raised an undisclosed amount in a Grant round on November 2, 2022.
What does Cerus do?
Cerus Corporation is dedicated solely to safeguarding the world’s blood supply and aims to become the preeminent global blood products company.
Where is Cerus based and how big is it?
Cerus is based in Concord, Massachusetts, United States. Fundz records about 620 employees.
Who are the decision-makers at Cerus?
Fundz holds 1 contact at Cerus, including the Research Staff. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Manufacturing and Biotechnology around the same time

Companies in the same sectors as Cerus that raised within 45 days of this round, from Fundz verified event records.

  • Evergreen Theragnostics raised $15M on December 15, 2022.
  • NewcelX raised $10M on December 13, 2022.
  • Experic raised $14M (Series B) on November 30, 2022.
  • MedX Health raised an undisclosed amount (Convertible Note) on November 18, 2022.
  • The Shape Sensing Company raised an undisclosed amount (Funding Round) on November 10, 2022.
  • Biocoat raised an undisclosed amount on November 2, 2022.

Who to call at Cerus, and when

A new round usually means Cerus is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Cerus raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Cerus, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Cerus. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Cerus

Location

Concord, Massachusetts, United States

About

Cerus Corporation is dedicated solely to safeguarding the world’s blood supply and aims to become the preeminent global blood products company. Headquartered in Concord, California, the company develops and supplies vital technologies and pathogen-protected blood components to blood centers, hospitals, and ultimately patients who rely on safe blood. The INTERCEPT Blood System for platelets and plasma is available globally and remains the only pathogen reduction system with both CE mark and FDA approval for these two blood components. The INTERCEPT red blood cell system is under regulatory review in Europe, and in late-stage clinical development in the US. Also in the US, the INTERCEPT Blood System for Cryoprecipitation is approved for the production of INTERCEPT Fibrinogen Complex, a therapeutic product for the treatment and control of bleeding, including massive hemorrhage, associated with fibrinogen deficiency. For more information about Cerus, visit www.cerus.com and follow us on LinkedIn. INTERCEPT and the INTERCEPT Blood System are trademarks of Cerus Corporation.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Cerus raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsChris M., Research Staff hidden hidden hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Cerus's next move

See what Strategic adds

Cerus raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.